▶ 調査レポート

世界の臨床試験(CTMS)市場規模・現状・予測(2021年-2027年)

• 英文タイトル:Global Clinical Trial Market Size, Status and Forecast 2021-2027

QYResearchが調査・発行した産業分析レポートです。世界の臨床試験(CTMS)市場規模・現状・予測(2021年-2027年) / Global Clinical Trial Market Size, Status and Forecast 2021-2027 / QYR2104Z1379資料のイメージです。• レポートコード:QYR2104Z1379
• 出版社/出版日:QYResearch / 2021年4月
※2025年版があります。お問い合わせください。

• レポート形態:英文、PDF、96ページ
• 納品方法:Eメール(納期:3日)
• 産業分類:医療
• 販売価格(消費税別)
  Single User¥565,500 (USD3,900)▷ お問い合わせ
  Multi User/Five User¥848,250 (USD5,850)▷ お問い合わせ
  Enterprise License(同一法人内共有可)¥1,131,000 (USD7,800)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
QYResearch社発行の本調査資料では、臨床試験(CTMS)のグローバル市場(2016年~2027年)について調べ、市場動向、主要企業の市場シェア、種類別市場規模(機器(製品)、消耗品、その他)、用途別市場規模(調達・備品、レンタル、その他)、主要地域別市場規模(北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等)、関連企業情報などを掲載しています。
・市場概要
・臨床試験(CTMS)の市場動向
・企業の競争状況、市場シェア
・臨床試験(CTMS)の種類別市場規模(機器(製品)、消耗品、その他)
・臨床試験(CTMS)の用途別市場規模(調達・備品、レンタル、その他)
・臨床試験(CTMS)の北米市場規模2016-2027(アメリカ、カナダ)
・臨床試験(CTMS)のヨーロッパ市場規模2016-2027(ドイツ、フランス、イギリス等)
・臨床試験(CTMS)のアジア市場規模2016-2027(日本、中国、韓国、インド、東南アジア等)
・臨床試験(CTMS)の中南米市場規模2016-2027(メキシコ、ブラジル)
・臨床試験(CTMS)の中東・アフリカ市場規模2016-2027(トルコ、サウジアラビア等)
・主要企業情報(Fisher Clinical Services、Myoderm、Bilcare、CliniChain、Ancillare、MESM、ERG Holding、Apex Medical Research、Parexel、PRA Health、LabCorp (Covance)、Marken、AmerisourceBergen (World Courier))
・結論

Clinical trials are experiments or observations done in clinical research. Such prospective biomedical or behavioral research studies on human participants are designed to answer specific questions about biomedical or behavioral interventions, including new treatments (such as novel vaccines, drugs, dietary choices, dietary supplements, and medical devices) and known interventions that warrant further study and comparison. Clinical trials generate data on safety and efficacy. They are conducted only after they have received health authority/ethics committee approval in the country where approval of the therapy is sought. These authorities are responsible for vetting the risk/benefit ratio of the trial – their approval does not mean that the therapy is ‘safe’ or effective, only that the trial may be conducted.
The industry’s leading producers are Parexel, PRA Health and LabCorp (Covance), which accounted for 4.94%, 7.25% and 11.81% of revenue in 2019, respectively. By region, North America has the highest share of income, at more than 39 percent.

Market Analysis and Insights: Global Clinical Trial Market
The global Clinical Trial market size is projected to reach US$ 71150 million by 2026, from US$ 39500 million in 2019, at a CAGR of 8.8% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Clinical Trial market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Clinical Trial market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Clinical Trial market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Clinical Trial market.

Global Clinical Trial Scope and Market Size
Clinical Trial market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Clinical Trial market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Instruments(Products)
Consumables
Others
Instruments(Products) and Consumables are estimated to account near 16% of revenue share in 2019.

Segment by Application
Procurement and Supplies
Rentals
Others
Procurement and Supplies are the most common application, which take up over 12% of the revenue share in 2019.

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Fisher Clinical Services
Myoderm
Bilcare
CliniChain
Ancillare
MESM
ERG Holding
Apex Medical Research
Parexel
CliniChain
Ancillare

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Clinical Trial Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Instruments(Products)
1.2.3 Consumables
1.2.4 Others
1.3 Market by Application
1.3.1 Global Clinical Trial Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Procurement and Supplies
1.3.3 Rentals
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Clinical Trial Market Perspective (2016-2027)
2.2 Clinical Trial Growth Trends by Regions
2.2.1 Clinical Trial Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Clinical Trial Historic Market Share by Regions (2016-2021)
2.2.3 Clinical Trial Forecasted Market Size by Regions (2022-2027)
2.3 Clinical Trial Industry Dynamic
2.3.1 Clinical Trial Market Trends
2.3.2 Clinical Trial Market Drivers
2.3.3 Clinical Trial Market Challenges
2.3.4 Clinical Trial Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Clinical Trial Players by Revenue
3.1.1 Global Top Clinical Trial Players by Revenue (2016-2021)
3.1.2 Global Clinical Trial Revenue Market Share by Players (2016-2021)
3.2 Global Clinical Trial Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Clinical Trial Revenue
3.4 Global Clinical Trial Market Concentration Ratio
3.4.1 Global Clinical Trial Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Clinical Trial Revenue in 2020
3.5 Clinical Trial Key Players Head office and Area Served
3.6 Key Players Clinical Trial Product Solution and Service
3.7 Date of Enter into Clinical Trial Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Clinical Trial Breakdown Data by Type
4.1 Global Clinical Trial Historic Market Size by Type (2016-2021)
4.2 Global Clinical Trial Forecasted Market Size by Type (2022-2027)

5 Clinical Trial Breakdown Data by Application
5.1 Global Clinical Trial Historic Market Size by Application (2016-2021)
5.2 Global Clinical Trial Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Clinical Trial Market Size (2016-2027)
6.2 North America Clinical Trial Market Size by Type
6.2.1 North America Clinical Trial Market Size by Type (2016-2021)
6.2.2 North America Clinical Trial Market Size by Type (2022-2027)
6.2.3 North America Clinical Trial Market Size by Type (2016-2027)
6.3 North America Clinical Trial Market Size by Application
6.3.1 North America Clinical Trial Market Size by Application (2016-2021)
6.3.2 North America Clinical Trial Market Size by Application (2022-2027)
6.3.3 North America Clinical Trial Market Size by Application (2016-2027)
6.4 North America Clinical Trial Market Size by Country
6.4.1 North America Clinical Trial Market Size by Country (2016-2021)
6.4.2 North America Clinical Trial Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Clinical Trial Market Size (2016-2027)
7.2 Europe Clinical Trial Market Size by Type
7.2.1 Europe Clinical Trial Market Size by Type (2016-2021)
7.2.2 Europe Clinical Trial Market Size by Type (2022-2027)
7.2.3 Europe Clinical Trial Market Size by Type (2016-2027)
7.3 Europe Clinical Trial Market Size by Application
7.3.1 Europe Clinical Trial Market Size by Application (2016-2021)
7.3.2 Europe Clinical Trial Market Size by Application (2022-2027)
7.3.3 Europe Clinical Trial Market Size by Application (2016-2027)
7.4 Europe Clinical Trial Market Size by Country
7.4.1 Europe Clinical Trial Market Size by Country (2016-2021)
7.4.2 Europe Clinical Trial Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Clinical Trial Market Size (2016-2027)
8.2 Asia-Pacific Clinical Trial Market Size by Type
8.2.1 Asia-Pacific Clinical Trial Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Clinical Trial Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Clinical Trial Market Size by Type (2016-2027)
8.3 Asia-Pacific Clinical Trial Market Size by Application
8.3.1 Asia-Pacific Clinical Trial Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Clinical Trial Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Clinical Trial Market Size by Application (2016-2027)
8.4 Asia-Pacific Clinical Trial Market Size by Region
8.4.1 Asia-Pacific Clinical Trial Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Clinical Trial Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Clinical Trial Market Size (2016-2027)
9.2 Latin America Clinical Trial Market Size by Type
9.2.1 Latin America Clinical Trial Market Size by Type (2016-2021)
9.2.2 Latin America Clinical Trial Market Size by Type (2022-2027)
9.2.3 Latin America Clinical Trial Market Size by Type (2016-2027)
9.3 Latin America Clinical Trial Market Size by Application
9.3.1 Latin America Clinical Trial Market Size by Application (2016-2021)
9.3.2 Latin America Clinical Trial Market Size by Application (2022-2027)
9.3.3 Latin America Clinical Trial Market Size by Application (2016-2027)
9.4 Latin America Clinical Trial Market Size by Country
9.4.1 Latin America Clinical Trial Market Size by Country (2016-2021)
9.4.2 Latin America Clinical Trial Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Clinical Trial Market Size (2016-2027)
10.2 Middle East & Africa Clinical Trial Market Size by Type
10.2.1 Middle East & Africa Clinical Trial Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Clinical Trial Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Clinical Trial Market Size by Type (2016-2027)
10.3 Middle East & Africa Clinical Trial Market Size by Application
10.3.1 Middle East & Africa Clinical Trial Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Clinical Trial Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Clinical Trial Market Size by Application (2016-2027)
10.4 Middle East & Africa Clinical Trial Market Size by Country
10.4.1 Middle East & Africa Clinical Trial Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Clinical Trial Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Fisher Clinical Services
11.1.1 Fisher Clinical Services Company Details
11.1.2 Fisher Clinical Services Business Overview
11.1.3 Fisher Clinical Services Clinical Trial Introduction
11.1.4 Fisher Clinical Services Revenue in Clinical Trial Business (2016-2021)
11.1.5 Fisher Clinical Services Recent Development
11.2 Myoderm
11.2.1 Myoderm Company Details
11.2.2 Myoderm Business Overview
11.2.3 Myoderm Clinical Trial Introduction
11.2.4 Myoderm Revenue in Clinical Trial Business (2016-2021)
11.2.5 Myoderm Recent Development
11.3 Bilcare
11.3.1 Bilcare Company Details
11.3.2 Bilcare Business Overview
11.3.3 Bilcare Clinical Trial Introduction
11.3.4 Bilcare Revenue in Clinical Trial Business (2016-2021)
11.3.5 Bilcare Recent Development
11.4 CliniChain
11.4.1 CliniChain Company Details
11.4.2 CliniChain Business Overview
11.4.3 CliniChain Clinical Trial Introduction
11.4.4 CliniChain Revenue in Clinical Trial Business (2016-2021)
11.4.5 CliniChain Recent Development
11.5 Ancillare
11.5.1 Ancillare Company Details
11.5.2 Ancillare Business Overview
11.5.3 Ancillare Clinical Trial Introduction
11.5.4 Ancillare Revenue in Clinical Trial Business (2016-2021)
11.5.5 Ancillare Recent Development
11.6 MESM
11.6.1 MESM Company Details
11.6.2 MESM Business Overview
11.6.3 MESM Clinical Trial Introduction
11.6.4 MESM Revenue in Clinical Trial Business (2016-2021)
11.6.5 MESM Recent Development
11.7 ERG Holding
11.7.1 ERG Holding Company Details
11.7.2 ERG Holding Business Overview
11.7.3 ERG Holding Clinical Trial Introduction
11.7.4 ERG Holding Revenue in Clinical Trial Business (2016-2021)
11.7.5 ERG Holding Recent Development
11.8 Apex Medical Research
11.8.1 Apex Medical Research Company Details
11.8.2 Apex Medical Research Business Overview
11.8.3 Apex Medical Research Clinical Trial Introduction
11.8.4 Apex Medical Research Revenue in Clinical Trial Business (2016-2021)
11.8.5 Apex Medical Research Recent Development
11.9 Parexel
11.9.1 Parexel Company Details
11.9.2 Parexel Business Overview
11.9.3 Parexel Clinical Trial Introduction
11.9.4 Parexel Revenue in Clinical Trial Business (2016-2021)
11.9.5 Parexel Recent Development
11.10 PRA Health
11.10.1 PRA Health Company Details
11.10.2 PRA Health Business Overview
11.10.3 PRA Health Clinical Trial Introduction
11.10.4 PRA Health Revenue in Clinical Trial Business (2016-2021)
11.10.5 PRA Health Recent Development
11.11 LabCorp (Covance)
11.11.1 LabCorp (Covance) Company Details
11.11.2 LabCorp (Covance) Business Overview
11.11.3 LabCorp (Covance) Clinical Trial Introduction
11.11.4 LabCorp (Covance) Revenue in Clinical Trial Business (2016-2021)
11.11.5 LabCorp (Covance) Recent Development
11.12 Marken
11.12.1 Marken Company Details
11.12.2 Marken Business Overview
11.12.3 Marken Clinical Trial Introduction
11.12.4 Marken Revenue in Clinical Trial Business (2016-2021)
11.12.5 Marken Recent Development
11.13 AmerisourceBergen (World Courier)
11.13.1 AmerisourceBergen (World Courier) Company Details
11.13.2 AmerisourceBergen (World Courier) Business Overview
11.13.3 AmerisourceBergen (World Courier) Clinical Trial Introduction
11.13.4 AmerisourceBergen (World Courier) Revenue in Clinical Trial Business (2016-2021)
11.13.5 AmerisourceBergen (World Courier) Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Clinical Trial Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Instruments(Products)
Table 3. Key Players of Consumables
Table 4. Key Players of Others
Table 5. Global Clinical Trial Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Clinical Trial Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Clinical Trial Market Size by Regions (2016-2021) & (US$ Million)
Table 8. Global Clinical Trial Market Share by Regions (2016-2021)
Table 9. Global Clinical Trial Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 10. Global Clinical Trial Market Share by Regions (2022-2027)
Table 11. Clinical Trial Market Trends
Table 12. Clinical Trial Market Drivers
Table 13. Clinical Trial Market Challenges
Table 14. Clinical Trial Market Restraints
Table 15. Global Clinical Trial Revenue by Players (2016-2021) & (US$ Million)
Table 16. Global Clinical Trial Market Share by Players (2016-2021)
Table 17. Global Top Clinical Trial Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Clinical Trial as of 2020)
Table 18. Ranking of Global Top Clinical Trial Companies by Revenue (US$ Million) in 2020
Table 19. Global 5 Largest Players Market Share by Clinical Trial Revenue (CR5 and HHI) & (2016-2021)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Clinical Trial Product Solution and Service
Table 22. Date of Enter into Clinical Trial Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Clinical Trial Market Size by Type (2016-2021) (US$ Million)
Table 25. Global Clinical Trial Revenue Market Share by Type (2016-2021)
Table 26. Global Clinical Trial Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 27. Global Clinical Trial Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 28. Global Clinical Trial Market Size Share by Application (2016-2021) & (US$ Million)
Table 29. Global Clinical Trial Revenue Market Share by Application (2016-2021)
Table 30. Global Clinical Trial Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 31. Global Clinical Trial Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 32. North America Clinical Trial Market Size by Type (2016-2021) (US$ Million)
Table 33. North America Clinical Trial Market Size by Type (2022-2027) & (US$ Million)
Table 34. North America Clinical Trial Market Size by Application (2016-2021) (US$ Million)
Table 35. North America Clinical Trial Market Size by Application (2022-2027) & (US$ Million)
Table 36. North America Clinical Trial Market Size by Country (2016-2021) & (US$ Million)
Table 37. North America Clinical Trial Market Size by Country (2022-2027) & (US$ Million)
Table 38. Europe Clinical Trial Market Size by Type (2016-2021) (US$ Million)
Table 39. Europe Clinical Trial Market Size by Type (2022-2027) & (US$ Million)
Table 40. Europe Clinical Trial Market Size by Application (2016-2021) (US$ Million)
Table 41. Europe Clinical Trial Market Size by Application (2022-2027) & (US$ Million)
Table 42. Europe Clinical Trial Market Size by Country (2016-2021) & (US$ Million)
Table 43. Europe Clinical Trial Market Size by Country (2022-2027) & (US$ Million)
Table 44. Asia-Pacific Clinical Trial Market Size by Type (2016-2021) (US$ Million)
Table 45. Asia-Pacific Clinical Trial Market Size by Type (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Clinical Trial Market Size by Application (2016-2021) (US$ Million)
Table 47. Asia-Pacific Clinical Trial Market Size by Application (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Clinical Trial Market Size by Region (2016-2021) & (US$ Million)
Table 49. Asia-Pacific Clinical Trial Market Size by Region (2022-2027) & (US$ Million)
Table 50. Latin America Clinical Trial Market Size by Type (2016-2021) (US$ Million)
Table 51. Latin America Clinical Trial Market Size by Type (2022-2027) & (US$ Million)
Table 52. Latin America Clinical Trial Market Size by Application (2016-2021) (US$ Million)
Table 53. Latin America Clinical Trial Market Size by Application (2022-2027) & (US$ Million)
Table 54. Latin America Clinical Trial Market Size by Country (2016-2021) & (US$ Million)
Table 55. Latin America Clinical Trial Market Size by Country (2022-2027) & (US$ Million)
Table 56. Middle East & Africa Clinical Trial Market Size by Type (2016-2021) (US$ Million)
Table 57. Middle East & Africa Clinical Trial Market Size by Type (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Clinical Trial Market Size by Application (2016-2021) (US$ Million)
Table 59. Middle East & Africa Clinical Trial Market Size by Application (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Clinical Trial Market Size by Country (2016-2021) & (US$ Million)
Table 61. Middle East & Africa Clinical Trial Market Size by Country (2022-2027) & (US$ Million)
Table 62. Fisher Clinical Services Company Details
Table 63. Fisher Clinical Services Business Overview
Table 64. Fisher Clinical Services Clinical Trial Product
Table 65. Fisher Clinical Services Revenue in Clinical Trial Business (2016-2021) & (US$ Million)
Table 66. Fisher Clinical Services Recent Development
Table 67. Myoderm Company Details
Table 68. Myoderm Business Overview
Table 69. Myoderm Clinical Trial Product
Table 70. Myoderm Revenue in Clinical Trial Business (2016-2021) & (US$ Million)
Table 71. Myoderm Recent Development
Table 72. Bilcare Company Details
Table 73. Bilcare Business Overview
Table 74. Bilcare Clinical Trial Product
Table 75. Bilcare Revenue in Clinical Trial Business (2016-2021) & (US$ Million)
Table 76. Bilcare Recent Development
Table 77. CliniChain Company Details
Table 78. CliniChain Business Overview
Table 79. CliniChain Clinical Trial Product
Table 80. CliniChain Revenue in Clinical Trial Business (2016-2021) & (US$ Million)
Table 81. CliniChain Recent Development
Table 82. Ancillare Company Details
Table 83. Ancillare Business Overview
Table 84. Ancillare Clinical Trial Product
Table 85. Ancillare Revenue in Clinical Trial Business (2016-2021) & (US$ Million)
Table 86. Ancillare Recent Development
Table 87. MESM Company Details
Table 88. MESM Business Overview
Table 89. MESM Clinical Trial Product
Table 90. MESM Revenue in Clinical Trial Business (2016-2021) & (US$ Million)
Table 91. MESM Recent Development
Table 92. ERG Holding Company Details
Table 93. ERG Holding Business Overview
Table 94. ERG Holding Clinical Trial Product
Table 95. ERG Holding Revenue in Clinical Trial Business (2016-2021) & (US$ Million)
Table 96. ERG Holding Recent Development
Table 97. Apex Medical Research Company Details
Table 98. Apex Medical Research Business Overview
Table 99. Apex Medical Research Revenue in Clinical Trial Business (2016-2021) & (US$ Million)
Table 100. Apex Medical Research Recent Development
Table 101. Parexel Company Details
Table 102. Parexel Business Overview
Table 103. Parexel Clinical Trial Product
Table 104. Parexel Revenue in Clinical Trial Business (2016-2021) & (US$ Million)
Table 105. Parexel Recent Development
Table 106. PRA Health Company Details
Table 107. PRA Health Business Overview
Table 108. PRA Health Clinical Trial Product
Table 109. PRA Health Revenue in Clinical Trial Business (2016-2021) & (US$ Million)
Table 110. PRA Health Recent Development
Table 111. LabCorp (Covance) Company Details
Table 112. LabCorp (Covance) Business Overview
Table 113. LabCorp (Covance) Clinical Trial Product
Table 114. LabCorp (Covance) Revenue in Clinical Trial Business (2016-2021) & (US$ Million)
Table 115. LabCorp (Covance) Recent Development
Table 116. Marken Company Details
Table 117. Marken Business Overview
Table 118. Marken Clinical Trial Product
Table 119. Marken Revenue in Clinical Trial Business (2016-2021) & (US$ Million)
Table 120. Marken Recent Development
Table 121. AmerisourceBergen (World Courier) Company Details
Table 122. AmerisourceBergen (World Courier) Business Overview
Table 123. AmerisourceBergen (World Courier) Clinical Trial Product
Table 124. AmerisourceBergen (World Courier) Revenue in Clinical Trial Business (2016-2021) & (US$ Million)
Table 125. AmerisourceBergen (World Courier) Recent Development
Table 126. Research Programs/Design for This Report
Table 127. Key Data Information from Secondary Sources
Table 128. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Clinical Trial Market Share by Type: 2020 VS 2027
Figure 2. Instruments(Products) Features
Figure 3. Consumables Features
Figure 4. Others Features
Figure 5. Global Clinical Trial Market Share by Application: 2020 VS 2027
Figure 6. Procurement and Supplies Case Studies
Figure 7. Rentals Case Studies
Figure 8. Others Case Studies
Figure 9. Clinical Trial Report Years Considered
Figure 10. Global Clinical Trial Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 11. Global Clinical Trial Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global Clinical Trial Market Share by Regions: 2020 VS 2027
Figure 13. Global Clinical Trial Market Share by Regions (2022-2027)
Figure 14. Global Clinical Trial Market Share by Players in 2020
Figure 15. Global Top Clinical Trial Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Clinical Trial as of 2020
Figure 16. The Top 10 and 5 Players Market Share by Clinical Trial Revenue in 2020
Figure 17. Global Clinical Trial Revenue Market Share by Type (2016-2021)
Figure 18. Global Clinical Trial Revenue Market Share by Type (2022-2027)
Figure 19. North America Clinical Trial Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 20. North America Clinical Trial Market Share by Type (2016-2027)
Figure 21. North America Clinical Trial Market Share by Application (2016-2027)
Figure 22. North America Clinical Trial Market Share by Country (2016-2027)
Figure 23. United States Clinical Trial Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Canada Clinical Trial Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Clinical Trial Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Clinical Trial Market Share by Type (2016-2027)
Figure 27. Europe Clinical Trial Market Share by Application (2016-2027)
Figure 28. Europe Clinical Trial Market Share by Country (2016-2027)
Figure 29. Germany Clinical Trial Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. France Clinical Trial Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. U.K. Clinical Trial Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Italy Clinical Trial Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Russia Clinical Trial Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Nordic Clinical Trial Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Clinical Trial Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Clinical Trial Market Share by Type (2016-2027)
Figure 37. Asia-Pacific Clinical Trial Market Share by Application (2016-2027)
Figure 38. Asia-Pacific Clinical Trial Market Share by Region (2016-2027)
Figure 39. China Clinical Trial Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Japan Clinical Trial Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. South Korea Clinical Trial Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Southeast Asia Clinical Trial Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. India Clinical Trial Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Australia Clinical Trial Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Clinical Trial Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Clinical Trial Market Share by Type (2016-2027)
Figure 47. Latin America Clinical Trial Market Share by Application (2016-2027)
Figure 48. Latin America Clinical Trial Market Share by Country (2016-2027)
Figure 49. Mexico Clinical Trial Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Brazil Clinical Trial Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Clinical Trial Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Clinical Trial Market Share by Type (2016-2027)
Figure 53. Middle East & Africa Clinical Trial Market Share by Application (2016-2027)
Figure 54. Middle East & Africa Clinical Trial Market Share by Country (2016-2027)
Figure 55. Turkey Clinical Trial Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Saudi Arabia Clinical Trial Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. UAE Clinical Trial Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Fisher Clinical Services Revenue Growth Rate in Clinical Trial Business (2016-2021)
Figure 59. Myoderm Revenue Growth Rate in Clinical Trial Business (2016-2021)
Figure 60. Bilcare Revenue Growth Rate in Clinical Trial Business (2016-2021)
Figure 61. CliniChain Revenue Growth Rate in Clinical Trial Business (2016-2021)
Figure 62. Ancillare Revenue Growth Rate in Clinical Trial Business (2016-2021)
Figure 63. MESM Revenue Growth Rate in Clinical Trial Business (2016-2021)
Figure 64. ERG Holding Revenue Growth Rate in Clinical Trial Business (2016-2021)
Figure 65. Apex Medical Research Revenue Growth Rate in Clinical Trial Business (2016-2021)
Figure 66. Parexel Revenue Growth Rate in Clinical Trial Business (2016-2021)
Figure 67. PRA Health Revenue Growth Rate in Clinical Trial Business (2016-2021)
Figure 68. LabCorp (Covance) Revenue Growth Rate in Clinical Trial Business (2016-2021)
Figure 69. Marken Revenue Growth Rate in Clinical Trial Business (2016-2021)
Figure 70. AmerisourceBergen (World Courier) Revenue Growth Rate in Clinical Trial Business (2016-2021)
Figure 71. Bottom-up and Top-down Approaches for This Report
Figure 72. Data Triangulation
Figure 73. Key Executives Interviewed